A chemical analysis of a vial labeled "retatrutide" bought from a Brooklyn corner store found no peptide in it at all, according to Futurism's write-up of CBS reporting on the gray-market peptide trade.

Retatrutide is Eli Lilly's injectable weight-loss candidate, which has not been released. That has not stopped knockoff vials carrying its name from turning up on convenience store shelves across the United States, in much the same retail slot that gas station kratom occupies.

What the vial actually contained

CBS sent samples to Jason Galpin, a bioorganic chemistry researcher at the University of Iowa. "It does not look anything like a peptide," he told the outlet, which is a blunt verdict on a product whose entire value proposition is that it is one.

Peptides are short chains of amino acids. What Galpin reported finding instead was phenylacetic acid, a filler compound Futurism describes as typically used in perfume and illicit amphetamine manufacturing.

Thirteen bacterial colonies

The contamination finding is the part that should stop people cold. The vial also contained at least 13 separate bacterial colonies, which Carl Ross, director of development at the University of Iowa's Center for Biocatalysis and Bioprocessing, told CBS could easily cause a dangerous infection.

Ross put it in terms nobody needs a chemistry degree to follow. "As kids, we're all taught to wash out cuts if we get cut," he said, while gray-market peptide users are "injecting bacteria under the skin where it could multiply. It's pretty terrifying."

Not a one-off

This is the second such test to land in as many months. Wired ran a similar exercise last month, buying "peptides" from a Brooklyn bodega and sending them to a lab, and found what Futurism characterizes as a chemical slurry that technicians could not even identify.

Two independent purchases, two labs, zero peptides. The pattern matters more than either result alone, because it suggests the problem is not one bad batch but the supply route itself.

Bottom line

The interesting question in legitimate peptide research is what the molecules do. The question raised by these analyses is far more basic: whether there is any molecule in the vial at all. Neither lab test found one.